「优甜生物」获数千万元天使轮融资，量产高端甜蛋白｜早起看早期

Core Viewpoint - The article discusses the recent angel round financing of "YouTian Biotechnology," which aims to scale up the production of the natural sweet protein "Soma Sweet" using synthetic biology technology, addressing the challenges of high costs and limited supply in the natural sweetener market [1][9]. Company Overview - YouTian Biotechnology was established in 2023 by Chui Junsheng, a serial entrepreneur with a background in biology from Nankai University. The company focuses on synthetic biology and aims to revolutionize the sweetener industry by developing Soma Sweet through microbial fermentation [1][9]. Product Development - Soma Sweet, a natural high-intensity sweet protein discovered in the West African yam fruit, is 3000 times sweeter than sucrose and has no aftertaste, making it suitable for various food applications [5][6]. - The company has developed a Bio-Sup™ technology platform that integrates gene analysis, AI protein structure optimization, and process development, allowing for the creation of multiple product lines, including Soma Sweet and various enzymes [1][12]. Market Potential - The demand for low-sugar and low-calorie food products is increasing globally, and the market for natural protein sweeteners is expected to grow significantly. YouTian Biotechnology aims to meet this demand by expanding its product line and collaborating with food and beverage companies [13]. Production Capabilities - The production facility is located in the Changzhou Liyang High-tech Zone, where a standardized and scalable fermentation production system is being established. The company has completed industrial-scale pilot production and is working on a production line with a capacity of 30 tons [13]. - The use of synthetic biology for the production of Soma Sweet allows for stable supply and cost reduction, addressing the previous challenges of low availability and high prices associated with natural extraction methods [9][12]. Investment and Future Plans - The recent funding from Changzhou Qihang Synthetic Biology Venture Capital Fund will be used to enhance production capacity, strengthen the research team, and accelerate market penetration of Soma Sweet [13].